The nuchal translucency test is an important ultrasound examination performed in the first trimester of pregnancy, usually between week 11+0 and week 13+6. During the examination, the thickness of fluid in the fetal neck area is measured, a measurement that helps assess the risk for certain chromosomal syndromes, including Down syndrome, Trisomy 18 and Trisomy 13.

Beyond measuring the translucency itself, the examination allows early assessment of gestational age, fetal heartbeat, number of fetuses, and sometimes also an initial impression of major anatomical structures. When the examination is performed by an experienced physician with advanced ultrasound equipment, significant information about pregnancy development can be obtained at an early stage.

Important to know: Nuchal translucency is a screening test - meaning it does not definitively diagnose a chromosomal problem, but rather assesses the level of risk. The final risk calculation is determined after completing the blood tests of the first trimester and second trimester biochemical screening. It is also possible to perform NIPT testing, genetic chip testing, exome  or additional diagnostic tests.

At Dr. Harak's clinic, the nuchal translucency test is performed with a professional, calm and personal approach, using advanced ultrasound equipment and high accuracy, to provide parents with clear, reliable and reassuring information from the very beginning of the journey.

The examination is designed not only to measure, but also to explain, accompany, and give you a sense of security in the early stages of pregnancy.

The information about the scope and nature of the examination is based on accepted guidelines in the field of fetal medicine, including FMF and ACOG.